Ukraine was pharma’s ‘darling’ of clinical trials. As war drags on, will the industry come...

[cafead]

via Before the war, Ukraine was becoming pharma’s “darling” of clinical trials, said Dr. Andreas Muehler, chief medical officer of Immunic Therapeutics, a U.S. and German biotech currently running four multiple sclerosis trials in the country.

article source